















Salivary gland neoplasms form a diverse 
group of tumors, with different histological 
characteristics and clinical behavior patterns.1-12 
This marked variation in histological grad-
ing and clinical classification means that the 
evaluation of these tumors requires extensive 
knowledge of anatomy and physiology, as well 
as expertise in pathology. Long-term follow-
up of patients with salivary gland neoplasms 
is mandatory1-9,11 because of the frequently 
indolent but relentlessly infiltrative behavior 
associated with late locoregional recurrence 
and distant metastasis.
Approximately 10-15% of salivary 
gland tumors are adenoid cystic carcinomas 
(ACC).1,2-9 This type of neoplasm was first 
described by Billroth in 1856 as a benign 
neoplasm and was named cylindroma for its 
cribriform appearance formed by tumor cells 
with cylindrical pseudolumina or pseudo-
spaces. ACC occurs most often in minor 
salivary glands and the submandibular gland, 
and less frequently in the sublingual and pa-
rotid glands.4,11 Other rare locations include 
the aerodigestive tract, minor salivary glands, 
lachrymal glands and adnexal skin glands. 
Most ACC patients are in their fifth and sixth 
decades of life, and females are slightly more 
affected than males.1,4,11
Three histological subtypes of ACC are 
known: cribriform, tubular and solid. They 
may occur either separately or together in the 
same tumor, and the solid subtype is the most 
aggressive1,4,12 (Figure 1). Perineural invasion is 
characteristic of these tumors1-12 and occurs in up 
to 60% of cases.6 Cervical metastasis is rare and 
occurs in only 8-13% of patients.3,7,11 Distant 
metastasis may occur in up to 50% of ACC 
patients during the course of the disease, with the 
lungs and bones as the most common sites.3,5
This paper reviews the management of 
ACC in the Head and Neck Service of the 
Department of Surgery in the teaching hos-
pital of Universidade Estadual de Campinas 
(Unicamp), in order to evaluate its degree of 
aggressiveness in our experience.
MATERIAL AND METHODS
From August 1993 to February 2003, 
21 patients with ACC in the salivary glands 
were treated in the Head and Neck Service 
of the Department of Surgery at Universi-
dade Estadual de Campinas (Unicamp). All 
patients whose treatment began before the 
start of this period were excluded from the 
present study.
Patients were classified according to their 
clinical stage, based on the 1998 criteria of 
the Union Internationale Contre le Cancer 
(UICC).
Imaging examinations were used in all 
cases. For early-stage major salivary gland 
tumors, ultrasound was the only imaging ex-
amination done. For minor salivary glands, all 
patients had preoperative computed tomogra-
phy (CT) scans to determine the extent of the 
local tumor in the palate. For major salivary 
glands, four patients also needed a CT scan to 
allow better assessment of the lesions.
Diagnoses were made on the basis of 
histological samples, always preoperatively, 
by means of either fine-needle aspiration 
(in case of major salivary glands) or incision 
biopsy (minor salivary glands). Thus, frozen 
sections were only utilized to confirm the 
diagnosis or verify that the surgical margins 
were negative.
All of the patients underwent surgery with 
curative intent and sixteen (76%) received ad-
juvant radiotherapy, five after local recurrence. 
Surgical management was applied only after 
physical examination, imaging scans (mainly 
for minor salivary gland tumors), clinical stag-
ing and histological assessment of the tumor. 
The type of surgery was planned on the basis 
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CONTEXT AND OBJECTIVE: Salivary gland 
tumor management requires long-term follow-up 
because of tumor indolence and possible late 
recurrence and distant metastasis. Adenoid cystic 
carcinoma (ACC) accounts for 10-15% of such 
tumors. The aim here was to evaluate surgical 
and clinical management, staging and follow-up 
of ACC patients in one academic institution.
DESIGN AND SETTING: Retrospective study at 
Head and Neck Service, Universidade Estadual 
de Campinas.
METHODS: Data on 21 patients treated between 
1993 and 2003 were reviewed. Management 
utilized clinical staging, histology and imaging. 
Major salivary gland tumor extent was routinely 
assessed by preoperative ultrasonography. Diag-
nosis, surgery type, margin type (negative/posi-
tive), postoperative radiotherapy and recurrence 
(presence/absence) were evaluated.
RESULTS: There were eleven major salivary 
gland tumors (52.3%), seven submandibular 
and four parotid. Ten patients (47.7%) had minor 
salivary gland ACC (all in palate), while the 
submandibular was the most frequently affected 
major one. Diagnoses were mostly via fine-needle 
aspiration (FNA) and incision biopsy. Frozen sec-
tions were used for six patients. There was good 
ultrasound/FNA correlation. Sixteen (76%) had 
postoperative radiotherapy. One (4.7%) died 
from ACC and five now have recurrent disease: 
three (14.2%) locoregional and two (9.5%) 
distant metastases.
CONCLUSION: Adenoid cystic carcinoma has 
locally aggressive behavior. In 21 cases, of ACC, 
the facial nerve was preserved in all except in 
the few with gross tumor involvement. Treatment 
was defined from physical examination, imaging, 
staging and histology.
KEY WORDS: Head and neck cancer. Salivary 
gland neoplasms. Adenoid cystic carcinoma. 
Neoplasm staging. Radiotherapy.
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of the primary tumor site and the locoregional 
occurrence of metastasis, and it involved 
partial or total maxillectomy, parotidectomy 
and transoral resections. Patients with cervical 
metastasis underwent neck dissection accord-
ing to the level of the metastasis, thus ranging 
from radical to selective neck dissection.
Positive or narrow margins, perineural in-
vasion or more aggressive histological subtypes 
(generally the solid type) were the criteria for 
deciding to utilize postoperative radiotherapy, 
and this was employed in sixteen cases.
RESULTS
The majority of the patients were female. 
For major salivary gland tumors, six patients 
(28.5%) were in stage I, three (14.3%) were 
in stage II, and two (9.4%) were in stage III. 
None of the patients had stage IV disease. For 
minor salivary gland tumors, seven patients 
(33.3%) were in stage I and three (14.3%) 
were in stage II. Two patients with subman-
dibular ACC were N1.
The imaging scans accurately depicted the 
extent of the primary lesion: none of the scans 
underassessed the stage of the tumoral lesions, 
as confirmed by intraoperative findings. In 
four patients who had either T2 or T3 lesions, 
or tumors invading adjacent structures, a to-
mography scan was used to complement the 
preoperative assessment. For minor salivary 
gland tumors, this examination was done on 
all patients to allow better assessment of the 
degree of maxillary sinus invasion.
The diagnosing of major salivary gland 
tumors by aspirate biopsy was possible in 11 
patients (52.3%) and in the case of one minor 
salivary gland tumor (4.7%). An incision 
biopsy was done in the cases of nine (42.8%) 
minor salivary gland tumors, and six cases 
(28.5%) required a frozen section biopsy dur-
ing surgery. Table 1 describes the diagnosis and 
treatment of all 21 patients.
Nine patients had tumors that showed 
perineural invasion, which is a common 
trend in this type of neoplasm6 that confirms 
its locally aggressive behavior. Tumors were 
located in the major salivary glands in 11 
patients (52.3%), of which four were in 
the parotid and seven in the submandibular 
glands. Ten patients (47.7%) had minor 
salivary gland tumors, all in the palate, one 
of them in the soft palate.
Among the parotid tumors, three were 
located in the superficial lobe and one in the 
deep lobe. Facial nerve resection was necessary 
in three patients, one in the main trunk and 
two in the mandibular and cervical branches, 
all due to local invasion.
Among the submandibular tumors, one 
case showed hypoglossal nerve invasion and 
resection was done for oncological purposes. 
Four cases required neck dissections (two 
selective and two radical).
All but one patient had a confirmed pre-
operative diagnosis of malignant salivary gland 
tumor. One patient had a preoperative aspirate 
biopsy that showed pleomorphic adenoma, 
but the final pathology report confirmed 
ACC. Among the frozen section biopsies 
for six patients with malignant lesions, ACC 
was accurately diagnosed in four patients 
(66.6%). The pathology reports revealed six 
close surgical margins (less than 2 mm): two 
in submandibular tumors and four in minor 
salivary gland tumors.
The pathology reports identified the tu-
bular subtype of ACC in eight cases (38%), 
the cribriform subtype in eight (38%) and the 
solid subtype in five (24%).
Six patients had local recurrence and were 
surgically salvaged. Four had minor salivary 
gland tumors of the palate and were treated 
with radical1 or partial3 maxillectomy. One 
patient had parotid ACC that required cra-
nial-facial resection because of invasion of the 
skull base, probably as a result of trigeminal 
nerve invasion.
One patient (4.7%), who had a T3N0 
submandibular tumor, died of the disease 40 
months after surgical treatment because of 
distant metastasis. Five patients had recurrence: 
three (14.2%) present with locoregional disease, 
one in the skull base and another in the maxil-
lary sinus recurrence. Two patients (9.5 %) now 
present distant pulmonary metastasis.
DISCUSSION
Salivary gland ACC has indolent behav-
ior, but is prone to late local recurrence.1,8,11,12 
The management of the 21 patients in 
this series was based on the clinical stage, 
histological subtype and ancillary imaging 
examinations. There were no T4 primary 
tumors among our patients. This finding, 
together with the relatively short follow-up in 
this series, meant that there were few distant 
metastases, in contrast to other reports.3-5,7-9 
There was a slight female predominance 
among the cases (66.6%), which was similar 
to what has been described in the literature 
from around the world.1,4,11 Most ACC oc-
curred in minor salivary glands and, when 
present in the major salivary glands, the 
submandibular gland was the one most fre-
quently affected. There were no cases with 
ACC in the sublingual glands.
According to the literature, the primary 
treatment of ACC is surgery with wide mar-
gins.1,2,4,9 In the present series, for parotid 
tumors, superficial parotidectomy was the 
standard procedure for stage I disease. Total pa-
rotidectomy was done when there was clinical 
invasion or suspicions of local tumor features. 
Preservation of the facial nerve was attempted 
in all cases, but the main trunk was sacrificed 
in one case because of gross tumor invasion 
(T3 lesion) that later showed invasion of the 
skull base and brain parenchyma (Figure 2). In 
Figure 1. Histology of adenoid cystic carcinoma subtypes (tubular and cribriform) and 
perineural invasion (400 x magnification and hematoxylin-eosin staining).





Table 1. Adenoid cystic carcinoma diagnosis treatment of 21 patients based on clinical stage: a case series report
Age;
sex





























resection Tubular Wide None None FOD
51
Female













Hard palate Incision biopsy
Aug 1995
T2N0M0




























parotidectomy Tubular Wide None Rtx FOD
54
Male

















Cribriform Wide None Rtx FOD
51
Female




















Cribriform Narrow Nov 1998
Rtx;
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Cribriform Narrow Feb 1999  Rtx; Ctx Pulmonary metastasis
68
Male





























parotidectomy Tubular Wide None None FOD
71
Female













Hard palate Incision biopsy
Oct 2002
T1N0M0
FNA Cribriform Wide Jun 2003 Maxillectomy + Rtx FOD
72
Male




tion Tubular Wide None None FOD
FNA = fine-needle aspiration; FOD = free of disease; Rtx = radiotherapy; Ctx = chemotherapy; SOND = Supraomohyoid neck dissection.
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one patient with invasion of the skull base and 
clearly showed neural invasion and its ascending 
route to the brain parenchyma (Figure 2).
For minor salivary gland ACC, all tumors 
were in the palate, with ten in the hard palate 
and one in the soft palate. Transoral resec-
tion was done on all T1 and T2 lesions with 
free margins up to 1 cm wide in order not 
to compromise the oncological safety of the 
surgery. Although the surgical field was limited 
in some cases, no close margins were reported. 
For larger tumors, maxillectomy was done by 
means of the Webber-Ferguson incision. No 
orbital exanteration was needed. 
CT scans were done for all minor salivary 
gland ACC in order to determine the tumor 
stage more precisely, to plan proper surgical 
intervention, and as a reference for future 
comparisons. Surgical margins were analyzed 
and, when close or positive, radiotherapy 
was indicated. Adjuvant radiotherapy was 
used for all cases of T3 tumors, even when 
the margins were free of disease. The portals 
were wide and encompassed all nerve routes 
because of the tendency of the tumors to show 
perineural invasion, as seen in nine of the 21 
patients (42.8%).
CONCLUSIONS
Adenoid cystic carcinoma is an indolent 
tumor with locally aggressive behavior and a 
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Figure 2. Invasion of the central nervous 
system by adenoid cystic carcinoma as 
shown in magnetic resonance imaging.
two T2 lesions, the cervicofacial trunk was also 
sacrificed because of tumor invasion.
Although nerve grafting is currently in-
dicated when the facial nerve is resected,1,8,9 
we only used grafting in cases of T1 and T2 
tumors, in patients ≤ 60 years old, or when ra-
diotherapy was not planned for the immediate 
postoperative period. No grafting was done in 
patients with a sacrificed nerve because of these 
patients’ advanced age and clinical stage.
Wide margins were always possible for 
submandibular gland tumors, while for T1 
and T2 lesions the adjacent level II lymph 
nodes were resected en bloc during subman-
dibulectomy. In cases of T3 lesions, subman-
dibulectomy with selective neck dissection 
(including one case of  supraomohyoid dis-
section) was done because the level II lymph 
nodes suffered from local tumor invasion, as 
confirmed by frozen section biopsies in N0 
patients. In N+ patients (with level I and II 
lymph nodes), modified radical neck dissec-
tion was done, with the accessory nerve being 
spared. Selective neck dissection for salivary 
gland tumors is controversial in N0 patients 
and is of little benefit to these patients.13,14
The imaging examinations for major sali-
vary gland tumors included ultrasound for all 
patients and CT scans only when invasion of 
the adjacent structures was suspected. Magnetic 
resonance imaging (MRI) was done in only 
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high rate of local recurrence, especially when 
perineural invasion is present. Radiotherapy is 
mandatory when disease-free margins cannot 
be obtained surgically and when there is locally 
advanced disease or high-grade histological 
findings. Long-term follow-up is needed 
because local recurrence and distant metas-
tasis may occur late in the course of disease, 
especially among high-risk patients.
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RESUMO
Conduta no carcinoma adenóide cístico de glândula salivar — série de casos em experiência institucional
CONTEXTO E OBJETIVO: Tumores de glândulas salivares exigem acompanhamento clínico por longos 
períodos devido à evolução indolente dessas neoplasias e à possibilidade tardia de recidivas locais 
e metástases a distância. O carcinoma adenóide cístico (CAC) compreende 10% a 15% dos tumores 
de glândulas salivares. O objetivo deste trabalho é analisar a conduta terapêutica, o estadiamento e o 
acompanhamento de pacientes com CAC em cabeça e pescoço em instituição de ensino.
TIPO DE ESTUDO E LOCAL: Estudo retrospectivo realizado no Serviço de Cirurgia de Cabeça e Pescoço, 
Universidade Estadual de Campinas.
MÉTODOS: Revemos o tratamento do CAC de 21 pacientes tratados entre 1993 e 2003. Os pacientes 
foram estadiados conforme os critérios clínicos da União Internacional Contra o Câncer (UICC) de 1998 
e o tratamento foi baseado na avaliação clínica e imagenológica.
RESULTADOS: 11 tumores estavam localizados nas glândulas salivares maiores (52,3%), sendo sete em 
glândula submandibular e quatro em parótida. Em 10 pacientes (47,7%), os tumores estavam em glându-
las salivares menores (todos em palato). Quando ocorreram em glândula salivar maior, a submandibular 
foi a mais acometida. O diagnóstico foi realizado quase sempre por punção aspirativa por agulha fina 
(PAAF) ou biópsia. Biópsia por congelação no intraoperatório foi realizada em seis pacientes. Obtivemos 
boa correlação entre o ultra-som e a PAAF. Em 16 pacientes (76%), a radioterapia pós-operatória foi 
realizada. Um dos pacientes (4,7%) foi a óbito pelo CAC e cinco tiveram recidivas da doença, sendo três 
locoregionais (14,2%) e dois (9,5%) por metástases a distância.
CONCLUSÃO: Carcinoma adenóide cístico apresenta comportamento agressivo localizado. Em 21 casos, 
o nervo facial foi preservado, exceto nos raros pacientes com invasão grosseira pelo tumor. O tratamento 
baseou-se no exame físico, exames de imagem, estágio do tumor e diferenciação histológica.
PALAVRAS-CHAVE: Carcinoma adenóide cístico. Estadiamento de neoplasias. Radioterapia. Neoplasias 
de cabeça e pescoço. Neoplasias das glândulas salivares
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